July 12, 2021
We believe Big Pharma’s familiarity with AR antagonism makes Essa a legitimate M&A candidate. Read More.
June 17, 2020
We believe there is tremendous upside for investors by owning Epigenomics ahead of, what we expect to be, a positive CMS reimbursement decision by August 28th. Read more.
April 27, 2020
We believe TLC can achieve a market cap of ~400mm this year based on positive TLC590 Ph2 data, and growing investor enthusiam towards the completion of the TLC599 Ph3 study. […]
November 25, 2019
We are initiating on Acasti Pharma as a high risk investment ideas. Read More.